№ lp_1_2_47693
Stakeholder commentary submitted to a European regulatory consultation outlining industry positions and concerns regarding proposed revisions to a pharmacovigilance guideline governing the management and submission of adverse reaction reports.
Date: 14 October 2016
Document type: Stakeholder comments
Subject: Good pharmacovigilance practices
Guideline reference: GVP Module VI (Rev 2)
Regulatory framework: European Union pharmacovigilance legislation
Organisation: European Federation of Pharmaceutical Industries and Associations (EFPIA)
Author: Sini Eskola
Recipient institution: European Medicines Agency
Related standards: ICH E2B (R2), ICH E2B (R3)
Key topics: Individual Case Safety Reports, adverse reaction reporting, EudraVigilance, validation rules, terminology consistency
Position of author: Industry stakeholder
Public disclosure status: Intended for publication by the Agency
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.